IP Library Granted Patent US 12,521,049
Granted Patent B2
US 12,521,049 · App. 17/340,788 · Granted Jan 13, 2026

Biological fluid separation device

Inventors: Kristin Weidemaier (Raleigh, NC); Alexander G. Lastovich (Gilbert, AZ); Qihua Xu (Cary, NC); Richard Abbott (Raleigh, NC)
Assignee: BECTON DICKINSON AND COMPANY
A61B5/150213A61B5/15003A61B5/150351A61B5/150755A61B5/154G01N33/491
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,521,049
App. No.
17/340,788
Granted
Jan 13, 2026
Kind
B2
Abstract

A blood separation device that allows high quality plasma to be generated using a single power source. The device includes a housing with an inlet port adapted to receive the blood sample, a first chamber having a first chamber flow channel in fluid communication with the inlet port, a second chamber having a second chamber flow channel, a separation member disposed between the first chamber and the second chamber. In some embodiments, the blood separation device detects or tests for the presence of a substance, such as an antigen or an antibody.

Claims (18)

1 . A blood separation device adapted to receive a blood sample having a whole blood portion and a plasma portion, the blood separation device comprising:

a housing including an inlet port adapted to receive the blood sample, a first chamber having a first chamber flow channel in fluid communication with the inlet port, a second chamber having a second chamber flow channel, a separation member disposed between the first chamber and the second chamber, a first well in fluid communication with the second chamber flow channel, a second well in fluid communication with the second chamber flow channel, a first vent adjacent to the inlet port, and a second vent adjacent to the first well and the second well; and

an actuator disposed at least partially within the housing and in communication with the inlet port, the first chamber, and the second chamber, the actuator being transitionable between an original position and a depressed position,

wherein after actuation of the actuator, as the actuator returns to the original position, the actuator applies a vacuum pressure to simultaneously draw the blood sample through the first chamber flow channel and the plasma portion through the separation member into the second chamber flow channel.

2 . The blood separation device of claim 1 , wherein the first well includes a first reagent.

3 . The blood separation device of claim 1 , wherein the second well includes a second reagent.

4 . The blood separation device of claim 1 , wherein the plasma portion simultaneously flows into the first well and the second well.

5 . The blood separation device of claim 4 , further comprising a whole blood reservoir in communication with the first chamber flow channel, wherein after the blood sample flows over the separation member, the whole blood portion flows into the whole blood reservoir.

6 . The blood separation device of claim 5 , further comprising a plasma reservoir in communication with the first well and the second well, wherein after the plasma portion fills the first well and the second well, excess plasma flows into the plasma reservoir.

7 . The blood separation device of claim 4 , wherein the housing includes a viewing window aligned with the first well and the second well, wherein the viewing window provides visualization of the first well and the second well from outside the housing.

8 . The blood separation device of claim 1 , further comprising:

a first valve located inside the housing, the first valve being transitionable between a first valve open position and a first valve closed position;

a second valve located inside the housing, the second valve being transitionable between a second valve open position and a second valve closed position; and

a third valve located at an external wall of the housing, the third valve being transitionable between a third valve open position and a third valve closed position.

9 . The blood separation device of claim 8 , wherein, with actuation of the actuator to the depressed position, the first valve is in the first valve closed position, the second valve is in the second valve closed position, and the third valve is in the third valve open position, and wherein, with the actuator transitioning from the depressed position to the original position, the first valve is in the first valve open position, the second valve is in the second valve open position, and the third valve is in the third valve closed position.

10 . The blood separation device of claim 1 , wherein the separation member is adapted to restrain the whole blood portion in the first chamber flow channel and allow the plasma portion to pass therethrough into the second chamber flow channel.

11 . The blood separation device of claim 1 , wherein the separation member comprises a track-etched membrane.

12 . The blood separation device of claim 1 , wherein the actuator is a push button.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 23, 2021
From: WEIDEMAIER, KRISTIN; LASTOVICH, ALEXANDER G.; XU, QIHUA; ABBOTT, RICHARD
To: BECTON DICKINSON AND COMPANY
Reel/Frame 056631/0275 →
Continuity (2)
Provisional Application 63036822 · Jun 9, 2020
Related Publication 20210378567A1 · Dec 9, 2021
References Cited (25)
US 5435970A · Mamenta · 1995 [cited by examiner]
US 9649061B2 · Ivosevic et al. · 2017 [cited by applicant]
US 10493409B2 · Xu et al. · 2019 [cited by applicant]
US 10549242B2 · Xu et al. · 2020 [cited by applicant]
US 10709370B2 · Xu et al. · 2020 [cited by applicant]
US 20050092662A1 · Gilbert et al. · 2005 [cited by applicant]
US 20050106066A1 · Saltsman et al. · 2005 [cited by applicant]
US 20160109467A1 · Kolb · 2016 [cited by examiner]
US 20170252706A1 · Xu · 2017 [cited by examiner]
US 20170354362A1 · Xu et al. · 2017 [cited by applicant]
US 20180071689A1 · Xu et al. · 2018 [cited by applicant]
CN 108885203A · 2018 [cited by applicant]
JP 2006517029A · 2006 [cited by applicant]
JP 2015172492A · 2015 [cited by applicant]
JP 2017538917A · 2017 [cited by applicant]
JP 2019513226A · 2019 [cited by applicant]
JP 2019520566A · 2019 [cited by applicant]
WO 2004065930A2 · 2004 [cited by applicant]
WO 2014182844A1 · 2014 [cited by applicant]
WO 2016105548A1 · 2016 [cited by applicant]
WO 2017151883A2 · 2017 [cited by applicant]
WO 2019058903A1 · 2019 [cited by applicant]
International Search Report and Written Opinion for Application No. PCT/US21/36131 dated Oct. 4, 2021 (11 pages). [cited by applicant]
Japanese Office Action issued in corresponding JP application No. 2022-575864 on Mar. 7, 2025, pp. 12. [cited by applicant]
Article 94(3) Communication issued in EP Application No. 21737852.0 on Apr. 22, 2025, pp. 5. [cited by applicant]